Xiaoou Xu1, Xiaojuan Zhang2, Xueniu Yang1. 1. NHC Key Laboratory of Birth Defects and Reproductive Health (Chongqing Key Laboratory of Birth Defects and Reproductive Health, Chongqing Population and Family Planning Science and Technology Research Institute), Chongqing 400020, China. 2. Department of Clinical Medicine, Chongqing Medical and Pharmaceutical College, Chongqing, China.
Abstract
To analyze the effect, side effects, and satisfaction of the second-generation radiopaque subcutaneous implant, providing healthcare workers a basis for propaganda and guidance. Methods: A total of 214 cases of healthy women with birth control requirements from August 2016 to June 2018 received ray subcutaneous implants. Quantitative surveys were administered 10 days, 3 months, 12 months, and 24 months later. All cases were implanted successfully. The number of effective cases was 211, with 3 cases lost to follow-up. The pregnancy rate of 211 subjects during receiving implant was 0. Changes in bleeding patterns (130 cases, 61.61%) remained the most common side effect event. The rate of withdrawal was 96.21% in the first year and 66.35% in the second year. There were 48 cases (67.61%) who withdrew due to the change of bleeding pattern. All participants with bleeding patterns were divided into the withdrawal group and the non-withdrawal group, and there were significant differences in educational background, number of pregnancies, abortion, and income between the two groups. According to the satisfaction survey, 37 (17.54%) were very satisfied, 109 (51.66%) were satisfied. The contraceptive rate of radiopaque subcutaneous implantation was very high, and there were no serious side effects while receiving an implant. The change of bleeding pattern was the main reason for withdrawal, which was related to educational background, number of pregnancies, history of abortion, and economic conditions. Pre-implantation consultation and post-implantation management should be strengthened.
To analyze the effect, side effects, and satisfaction of the second-generation radiopaque subcutaneous implant, providing healthcare workers a basis for propaganda and guidance. Methods: A total of 214 cases of healthy women with birth control requirements from August 2016 to June 2018 received ray subcutaneous implants. Quantitative surveys were administered 10 days, 3 months, 12 months, and 24 months later. All cases were implanted successfully. The number of effective cases was 211, with 3 cases lost to follow-up. The pregnancy rate of 211 subjects during receiving implant was 0. Changes in bleeding patterns (130 cases, 61.61%) remained the most common side effect event. The rate of withdrawal was 96.21% in the first year and 66.35% in the second year. There were 48 cases (67.61%) who withdrew due to the change of bleeding pattern. All participants with bleeding patterns were divided into the withdrawal group and the non-withdrawal group, and there were significant differences in educational background, number of pregnancies, abortion, and income between the two groups. According to the satisfaction survey, 37 (17.54%) were very satisfied, 109 (51.66%) were satisfied. The contraceptive rate of radiopaque subcutaneous implantation was very high, and there were no serious side effects while receiving an implant. The change of bleeding pattern was the main reason for withdrawal, which was related to educational background, number of pregnancies, history of abortion, and economic conditions. Pre-implantation consultation and post-implantation management should be strengthened.
Entities:
Keywords:
Contraception; Radiopaque; Side effects; Subcutaneous implantation
Authors: M Murat Inal; Yusuf Yildirim; Kenan Ertopcu; M Eftal Avci; Isa Ozelmas; Sivekar Tinar Journal: Eur J Contracept Reprod Health Care Date: 2008-09 Impact factor: 1.848
Authors: Luis Bahamondes; Cecilia Monteiro-Dantas; Ximena Espejo-Arce; Arlete M Dos Santos Fernandes; Jeffrey F Lui-Filho; Marcos Perrotti; Carlos A Petta Journal: Hum Reprod Date: 2005-10-27 Impact factor: 6.918
Authors: Peter Schnabel; Gabriele S Merki-Feld; Alice Malvy; Ingrid Duijkers; Ellen Mommers; Michiel W van den Heuvel Journal: Clin Drug Investig Date: 2012-06-01 Impact factor: 2.859
Authors: Cristina A F Guazzelli; Flaviano Teixeira de Queiroz; Marcia Barbieri; Maria Regina Torloni; Fabio Fernando de Araujo Journal: Contraception Date: 2010-09-24 Impact factor: 3.375
Authors: Mia Schmidt-Hansen; James E Hawkins; Jonathan Lord; Kelly Williams; Patricia A Lohr; Elise Hasler; Sharon Cameron Journal: Hum Reprod Update Date: 2020-02-28 Impact factor: 15.610